Long-Term Care Facilities, Pharmacy and Research

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Long-Term Care Facilities

Pharmacy

Research

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

The Pharma Data

NOVEMBER 8, 2020

Ready-to-dilute and room temperature stable, Sesquient is the only FDA-approved fosphenytoin that allows point-of-care storage, as well as fast and efficient administration in emergency rooms, intensive care units, first responder vehicles, and long-term care facilities, where serial seizures such as status epilepticus are most commonly treated.

FDA Approval

FDA Approval FDA Long-Term Care Facilities Treatment

‘Warp Speed’ Officials Say U.S. COVID Vaccine Distribution Too Slow

The Pharma Data

DECEMBER 31, 2020

According to the Times , he said that health care facilities are still learning how to store the vaccines at super-low temperatures, and many states are setting aside doses for use at long-term care facilities, an effort that’s expected to take several months.

Vaccine

Vaccine Long-Term Care Facilities Virus Hospitals

Drug Discovery Digest

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

‘Warp Speed’ Officials Say U.S. COVID Vaccine Distribution Too Slow

Stay Connected